Find Paper, Faster
Example:10.1021/acsami.1c06204 or Chem. Rev., 2007, 107, 2411-2502
SEQing to find hidden medulloblastoma cells
Cancer Cell  (IF31.743),  Pub Date : 2021-10-21, DOI: 10.1016/j.ccell.2021.09.014
John R. Prensner, Scott L. Pomeroy

Minimal residual disease (MRD) assessment has revolutionized the clinical management of pediatric leukemias but has remained challenging to implement in pediatric brain tumors. In this issue of Cancer Cell, Liu et al. describe an approach to measuring MRD in pediatric medulloblastoma through the use of cell-free DNA in cerebrospinal fluid, with important prognostic implications.